Aldeyra Therapeutics (ALDX) said Tuesday that patient-reported ocular discomfort and itching were "statistically lower" with reproxalap compared with...
Aldeyra Therapeutics (ALDX) said Tuesday it completed enrollment in the first part of the phase 3 trial of ADX-2191 in patients with proliferative...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Health care stocks held small gains ahead of Tuesday's close, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR ETF (XLV)...
Health care stocks were edging higher Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR ETF (XLV) both up about...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Aldeyra Therapeutics (ALDX) was sinking over 51%, staying within close range of its drop to its lowest share price since July 2020, after it said its...
Aldeyra Therapeutics (ALDX) said late Monday the phase 3 Tranquility trial of its investigational product candidate to treat dry eye disease missed the...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
US stocks were set for a higher open Tuesday, supported by upbeat earnings from apparel company Nike (NKE) and chipmaker Micron Technologies (MU). The Dow...